{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:04Z","timestamp":1792800724793,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LF V\u00e4sterbotten L\u00e4ns Landsting","award":["ALFVLL-369861"],"award-info":[{"award-number":["ALFVLL-369861"]}],"id":[{"id":"https:\/\/ror.org\/04t50sy53","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014-3241"],"award-info":[{"award-number":["2014-3241"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Insamlingstiftelsen","award":["FS 2.1.12-1605-14"],"award-info":[{"award-number":["FS 2.1.12-1605-14"]}]},{"name":"Biochemical Imaging Platform","award":["N.A."],"award-info":[{"award-number":["N.A."]}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["N.A."],"award-info":[{"award-number":["N.A."]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vetenskapsr\u00e5dent","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"FP-7 Marie Curie Action \u201cNano-Guard\u201d","award":["269138"],"award-info":[{"award-number":["269138"]}]},{"name":"FP-7 Marie Curie Action \u201cNano-Guard\u201d","award":["269138"],"award-info":[{"award-number":["269138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1210-9","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:45:00Z","timestamp":1528116300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Co-aggregation of pro-inflammatory S100A9 with \u03b1-synuclein in Parkinson\u2019s disease: ex vivo and in vitro studies"],"prefix":"10.1186","volume":"15","author":[{"given":"Istvan","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Iashchishyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A.","family":"Moskalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian K. T. S.","family":"W\u00e4rml\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmilla A.","family":"Morozova-Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"issue":"2","key":"1210_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN. alpha-Synuclein misfolding and Parkinson\u2019s disease. Biochim Biophys Acta. 2012;1822(2):261\u201385.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1210_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, Kagedal K, Halliday GM. Alpha-synuclein biology in Lewy body diseases. Alzheimers Res Ther. 2014;6(5):73.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1210_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14(1):38\u201348.","journal-title":"Nat Rev Neurosci"},{"key":"1210_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00592","volume":"2","author":"J Diao","year":"2013","unstructured":"Diao J, Burre J, Vivona S, Cipriano DJ, Sharma M, Kyoung M, Sudhof TC, Brunger AT. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2. Elife. 2013;2:e00592.","journal-title":"Elife"},{"issue":"6645","key":"1210_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340.","journal-title":"Nature"},{"issue":"1","key":"1210_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13\u201324.","journal-title":"Nat Rev Neurol"},{"key":"1210_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci. 2009;24:114\u201325.","journal-title":"Front Neurol Neurosci"},{"issue":"10","key":"1210_CR8","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, Hetzer C, Loher T, Vilar M, Campioni S, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011;108(10):4194\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1210_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P. Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord. 2013;28(1):31\u201340.","journal-title":"Mov Disord"},{"issue":"7","key":"1210_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1210_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/bpa.12371","volume":"26","author":"S Lim","year":"2016","unstructured":"Lim S, Chun Y, Lee JS, Lee SJ. Neuroinflammation in synucleinopathies. Brain Pathol. 2016;26(3):404\u20139.","journal-title":"Brain Pathol"},{"issue":"4","key":"1210_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8(4):382\u201397.","journal-title":"Lancet Neurol"},{"key":"1210_CR13","first-page":"436813","volume":"2011","author":"CC Ferrari","year":"2011","unstructured":"Ferrari CC, Tarelli R. Parkinson\u2019s disease and systemic inflammation. Parkinsons Dis. 2011;2011:436813.","journal-title":"Parkinsons Dis"},{"issue":"10","key":"1210_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology. 2011;76(10):863\u20139.","journal-title":"Neurology"},{"issue":"32","key":"1210_CR15","doi-asserted-by":"publisher","first-page":"16485","DOI":"10.1074\/jbc.R116.714576","volume":"291","author":"J Luo","year":"2016","unstructured":"Luo J, Warmlander SK, Graslund A, Abrahams JP. Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins: a further aspect of the amyloid cascade hypothesis. J Biol Chem. 2016;291(32):16485\u201393.","journal-title":"J Biol Chem"},{"issue":"40","key":"1210_CR16","doi-asserted-by":"publisher","first-page":"14236","DOI":"10.1002\/chem.201601830","volume":"22","author":"M Chemerovski-Glikman","year":"2016","unstructured":"Chemerovski-Glikman M, Rozentur-Shkop E, Richman M, Grupi A, Getler A, Cohen HY, Shaked H, Wallin C, Warmlander SK, Haas E, et al. Self-assembled cyclic d,l-alpha-peptides as generic conformational inhibitors of the alpha-synuclein aggregation and toxicity: in vitro and mechanistic studies. Chemistry. 2016;22(40):14236\u201346.","journal-title":"Chemistry"},{"issue":"9","key":"1210_CR17","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/ja310064v","volume":"135","author":"M Richman","year":"2013","unstructured":"Richman M, Wilk S, Chemerovski M, Warmlander SK, Wahlstrom A, Graslund A, Rahimipour S. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-alpha-peptide architecture. J Am Chem Soc. 2013;135(9):3474\u201384.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1210_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-013-1208-4","volume":"127","author":"C Wang","year":"2014","unstructured":"Wang C, Klechikov AG, Gharibyan AL, Warmlander SK, Jarvet J, Zhao L, Jia X, Shankar SK, Olofsson A, Brannstrom T, et al. The role of pro-inflammatory S100A9 in Alzheimer\u2019s disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127(4):507\u201322.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1210_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/156652413804486214","volume":"13","author":"R Donato","year":"2013","unstructured":"Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Functions of S100 proteins. Curr Mol Med. 2013;13(1):24\u201357.","journal-title":"Curr Mol Med"},{"issue":"10","key":"1210_CR20","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/acschemneuro.7b00251","volume":"8","author":"IA Iashchishyn","year":"2017","unstructured":"Iashchishyn IA, Sulskis D, Nguyen Ngoc M, Smirnovas V, Morozova-Roche LA. Finke-Watzky two-step nucleation-autocatalysis model of S100A9 amyloid formation: protein misfolding as \u201cnucleation\u201d event. ACS Chem Neurosci. 2017;8(10):2152\u20138.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1210_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008840","volume":"5","author":"TY Ha","year":"2010","unstructured":"Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, Suh YH. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One. 2010;5(1):e8840.","journal-title":"PLoS One"},{"issue":"6","key":"1210_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s004010050938","volume":"96","author":"HJ Schluesener","year":"1998","unstructured":"Schluesener HJ, Kremsner PG, Meyermann R. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol. 1998;96(6):575\u201380.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1210_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7","volume":"19","author":"E Postler","year":"1997","unstructured":"Postler E, Lehr A, Schluesener H, Meyermann R. Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions. Glia. 1997;19(1):27\u201334.","journal-title":"Glia"},{"issue":"11","key":"1210_CR24","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.neurobiolaging.2005.09.033","volume":"27","author":"CE Shepherd","year":"2006","unstructured":"Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, Geczy CL, Halliday GM. Inflammatory S100A9 and S100A12 proteins in Alzheimer\u2019s disease. Neurobiol Aging. 2006;27(11):1554\u201363.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1210_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s004019900172","volume":"100","author":"S Engel","year":"2000","unstructured":"Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, Wehner HD, Meyermann R. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol. 2000;100(3):313\u201322.","journal-title":"Acta Neuropathol"},{"key":"1210_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/srep01215","volume":"3","author":"WR Swindell","year":"2013","unstructured":"Swindell WR, Johnston A, Xing X, Little A, Robichaud P, Voorhees JJ, Fisher G, Gudjonsson JE. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci Rep. 2013;3:1215.","journal-title":"Sci Rep"},{"issue":"Pt 11","key":"1210_CR27","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"K Sathe","year":"2012","unstructured":"Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, Schulte C, Mustafa S, Synofzik M, Vukovic Z, et al. S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain. 2012;135(Pt 11):3336\u201347.","journal-title":"Brain"},{"issue":"3","key":"1210_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1468-1331.2006.01667.x","volume":"14","author":"KR Wilhelm","year":"2007","unstructured":"Wilhelm KR, Yanamandra K, Gruden MA, Zamotin V, Malisauskas M, Casaite V, Darinskas A, Forsgren L, Morozova-Roche LA. Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson\u2019s disease patients. Eur J Neurol. 2007;14(3):327\u201334.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1210_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2011.01.005","volume":"42","author":"J Liu","year":"2011","unstructured":"Liu J, Wang H, Zhang L, Xu Y, Deng W, Zhu H, Qin C. S100B transgenic mice develop features of Parkinson\u2019s disease. Arch Med Res. 2011;42(1):1\u20137.","journal-title":"Arch Med Res"},{"key":"1210_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep12531","volume":"5","author":"SK Sharma","year":"2015","unstructured":"Sharma SK, Chorell E, Steneberg P, Vernersson-Lindahl E, Edlund H, Wittung-Stafshede P. Insulin-degrading enzyme prevents alpha-synuclein fibril formation in a nonproteolytical manner. Sci Rep. 2015;5:12531.","journal-title":"Sci Rep"},{"issue":"11","key":"1210_CR31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.bbamcr.2006.08.028","volume":"1763","author":"T Vogl","year":"2006","unstructured":"Vogl T, Leukert N, Barczyk K, Strupat K, Roth J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim Biophys Acta. 2006;1763(11):1298\u2013306.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1210_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1369\/jhc.2009.953612","volume":"57","author":"G Glass","year":"2009","unstructured":"Glass G, Papin JA, Mandell JW. SIMPLE: a sequential immunoperoxidase labeling and erasing method. J Histochem Cytochem. 2009;57(10):899\u2013905.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"1210_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1369\/jhc.2009.953240","volume":"57","author":"D Pirici","year":"2009","unstructured":"Pirici D, Mogoanta L, Kumar-Singh S, Pirici I, Margaritescu C, Simionescu C, Stanescu R. Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype. J Histochem Cytochem. 2009;57(6):567\u201375.","journal-title":"J Histochem Cytochem"},{"issue":"14","key":"1210_CR34","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1074\/jbc.M010907200","volume":"276","author":"VN Uversky","year":"2001","unstructured":"Uversky VN, Li J, Fink AL. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem. 2001;276(14):10737\u201344.","journal-title":"J Biol Chem"},{"issue":"5","key":"1210_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jmb.2011.09.044","volume":"414","author":"X Jia","year":"2011","unstructured":"Jia X, Gharibyan AL, Ohman A, Liu Y, Olofsson A, Morozova-Roche LA. Neuroprotective and nootropic drug Noopept rescues alpha-synuclein amyloid cytotoxicity. J Mol Biol. 2011;414(5):699\u2013712.","journal-title":"J Mol Biol"},{"issue":"4","key":"1210_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R Jr, Browne G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol. 2001;307(4):1061\u201373.","journal-title":"J Mol Biol"},{"key":"1210_CR37","doi-asserted-by":"publisher","unstructured":"Horvath I, Werner T, Kumar R, Wittung-Stafshede P. Copper chaperone blocks amyloid formation via ternary complex. Q Rev Biophys. 2018;51 https:\/\/doi.org\/10.1017\/S0033583518000045 .","DOI":"10.1017\/S0033583518000045"},{"issue":"3","key":"1210_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1214\/ss\/1032280214","volume":"11","author":"TJ DiCiccio","year":"1996","unstructured":"DiCiccio TJ, Efron B. Bootstrap confidence intervals. Statist Sci. 1996;11(3):189\u2013228.","journal-title":"Statist Sci"},{"key":"1210_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ. An introduction to the bootstrap. New York [etc.]: Chapman & Hall; 1993."},{"issue":"2","key":"1210_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47(2):495\u2013508.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1210_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","volume":"88","author":"I Ferrer","year":"2009","unstructured":"Ferrer I. Early involvement of the cerebral cortex in Parkinson\u2019s disease: convergence of multiple metabolic defects. Prog Neurobiol. 2009;88(2):89\u2013103.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"1210_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS. Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol. 1996;55(3):259\u201372.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1210_CR43","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1136\/ard.2007.077800","volume":"67","author":"PL van Lent","year":"2008","unstructured":"van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J. Myeloid-related proteins S100A8\/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis. 2008;67(12):1750\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1210_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","volume":"32","author":"MM Averill","year":"2012","unstructured":"Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol. 2012;32(2):223\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1210_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00726-010-0528-0","volume":"41","author":"J Goyette","year":"2011","unstructured":"Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids. 2011;41(4):821\u201342.","journal-title":"Amino Acids"},{"issue":"3","key":"1210_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.febslet.2011.01.009","volume":"585","author":"DP Hong","year":"2011","unstructured":"Hong DP, Xiong W, Chang JY, Jiang C. The role of the C-terminus of human alpha-synuclein: intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers. FEBS Lett. 2011;585(3):561\u20136.","journal-title":"FEBS Lett"},{"issue":"50","key":"1210_CR47","doi-asserted-by":"publisher","first-page":"42233","DOI":"10.1074\/jbc.M112.396416","volume":"287","author":"HM Botelho","year":"2012","unstructured":"Botelho HM, Leal SS, Cardoso I, Yanamandra K, Morozova-Roche LA, Fritz G, Gomes CM. S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation. J Biol Chem. 2012;287(50):42233\u201342.","journal-title":"J Biol Chem"},{"issue":"4","key":"1210_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018513","volume":"6","author":"K Yanamandra","year":"2011","unstructured":"Yanamandra K, Gruden MA, Casaite V, Meskys R, Forsgren L, Morozova-Roche LA. \u03b1-Synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson\u2019s disease patients. PLoS One. 2011;6(4):e18513.","journal-title":"PLoS One"},{"issue":"2","key":"1210_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1210-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1210-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1210-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T04:04:45Z","timestamp":1720325085000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1210-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1210-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures with tissue samples were approved by the Medical Ethics Committees of the Institute of Neurology, Medical University of Vienna, Austria, and the Ume\u00e5 University Hospital, Sweden.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"172"}}